Page last updated: 2024-10-19

niacinamide and Colonic Inertia

niacinamide has been researched along with Colonic Inertia in 2 studies

nicotinamide : A pyridinecarboxamide that is pyridine in which the hydrogen at position 3 is replaced by a carboxamide group.

Colonic Inertia: Symptom characterized by the passage of stool once a week or less.

Research Excerpts

ExcerptRelevanceReference
"This phase Ib study evaluated the safety, pharmacokinetics, pharmacodynamics, and antitumor activity of AMG 102, a fully human monoclonal antibody against hepatocyte growth factor/scatter factor (HGF/SF), in combination with bevacizumab or motesanib in patients with advanced solid tumors."2.75A phase Ib study of AMG 102 in combination with bevacizumab or motesanib in patients with advanced solid tumors. ( Anderson, A; Beaupre, DM; Deng, H; Leitch, IM; Oliner, KS; Park, DJ; Rosen, PJ; Shubhakar, P; Sweeney, CJ; Yee, LK; Zhu, M, 2010)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Rosen, PJ1
Sweeney, CJ1
Park, DJ1
Beaupre, DM1
Deng, H1
Leitch, IM1
Shubhakar, P1
Zhu, M1
Oliner, KS1
Anderson, A1
Yee, LK1
Astegiano, M1
Pellicano, R1
Terzi, E1
Simondi, D1
Rizzetto, M1

Trials

1 trial available for niacinamide and Colonic Inertia

ArticleYear
A phase Ib study of AMG 102 in combination with bevacizumab or motesanib in patients with advanced solid tumors.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2010, May-01, Volume: 16, Issue:9

    Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineopl

2010

Other Studies

1 other study available for niacinamide and Colonic Inertia

ArticleYear
Treatment of irritable bowel syndrome. A case control experience.
    Minerva gastroenterologica e dietologica, 2006, Volume: 52, Issue:4

    Topics: Abdominal Pain; Adult; Angelica; Antidepressive Agents, Second-Generation; Case-Control Studies; Chi

2006